News

Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have discovered a ...
Another possibility is that cancer cells that have lost their Y chromosome somehow induce Y-chromosome loss, or general chromosomal instability, in surrounding immune cells through an unknown factor.
A new AI tool, AAnet, has discovered five distinct cell types within tumors, offering a deeper look into cancer's inner diversity. This insight could transform how we treat cancer, enabling more ...
Scientists at Nagoya University in Japan studied what happens when macrophages—a type of immune cell—encounter dying cancer ...
A new study shows that cells in atherosclerotic blood vessels grow in a way that resembles tumor development. This finding ...
A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI ...
Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...
New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...
However, a few modification sites showed cell type specifics. Zhou found that tRNA expressions are largely dysregulated, or altered, in cancerous mammary cell lines compared to the benign cells.
Background: Anti-PD- (L) 1 monotherapy has been the standard first-line treatment for PD-L1 positive NSCLC, but its clinical benefit remains unsatisfactory. Benmelstobart (TQB2450) is a humanized ...
Fast Track Designation (FTD) granted for the treatment of patients with metastatic PDAC with high IL1RAP expression levels.Reflects high unmet medical need in metastatic PDAC.Facilitates further devel ...